We are accelerating novel treatments to patients who need them.

Our vision

There are numerous unmet medical needs for many types of diseases. We are particularly interested in developing novel treatments for rare diseases. Many molecules are only partially progressed through the development cycle. The reasons vary for this, but we want to come alongside pharma companies and develop some of those molecules. We will take them all the way to registration and marketing, in collaboration with the pharma originator. To find out more about the types of molecules we are seeking, email Dr. Lorna Speid at LSPEID@SNDTM.COM. We have funding lined up for the first start-up called Cheetah Therapeutics, which focuses on oncology. The other spin-out companies will license-in molecules for other disease areas, mostly focused on rare diseases, or unmet medical needs. We are excited about the prospect for new treatments for patients currently unserved, or under-served.